Advaxis Inc. buy melinda
Start price
06.02.17
/
50%
€126.51
Target price
19.06.17
€135.30
Performance (%)
-34.65%
End price
19.06.17
€82.67
Summary
This prediction ended on 19.06.17 with a price of €82.67. Massive losses of -34.65% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Advaxis Inc. | - | - | - | - |
| iShares Core DAX® | 1.001% | -1.218% | 13.263% | 60.023% |
| iShares Nasdaq 100 | -1.447% | -4.597% | 0.414% | 85.321% |
| iShares Nikkei 225® | 8.406% | 8.425% | 27.328% | 61.038% |
| iShares S&P 500 | -0.226% | -2.451% | 0.167% | 57.738% |
Comments by melinda for this prediction
In the thread Advaxis Inc. diskutieren
Gebärmutterhalskrebs
Advaxis kündigt die erste Patientenbehandlung in der globalen Phase - 3 - Studie für AIM2CERV hohes Risiko, lokal fortgeschrittenem Gebärmutterhalskrebs
(Vom Mitglied beendet)